William M Mitchell insider trades: AIM ImmunoTech (AIM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where William reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 11, 2025 | AIM | ↑ Buy | 196,851 | $0.03 | $5K | Direct | Apr 23, 2025 (12d) |
| Dec 19, 2024 | AIM | ↓ Sell | 4,580 | $0.19 | $884 | Direct | Dec 20, 2024 (1d) |
| Jun 21, 2019 | HEB | ↑ Buy | 9,677 | $4.03 | $39K | Direct | Jun 24, 2019 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AIM insiders
Open-market trades in the last 12 months
About William M Mitchell's insider trades
William M Mitchell is a director at AIM ImmunoTech (AIM). Since Jun 21, 2019, William has reported 2 open-market purchases worth $44K and 1 sale worth $884 on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (45 filings), other transactions (17 filings), conversions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AIM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.